Table 2.

Outcomes of patients

Parameter	Total (n = 45)	SCT (n = 17)	P (SCT vs. Chemo)	MST (n = 11)	P (SCT vs. MST)	Chemo (n = 17)	P (MST vs. Chemo)
Median time of ANC recovery (range), days	12 (8-18)	9 (8-14)	< .001	12 (10-17)	< .001	12 (10-18)	.462
Median time of platelet recovery (range), days	13 (6-18)	10 (6-15)	< .001	13.5 (7-18)	< .001	13 (10-18)	.969
Severe adverse event, n (%)			< .001		< .001		.132
Severe infections	6 (13)	2 (12)		0 (0)		4 (24)
III-IV aGVHD	2 (4)	2 (12)		0 (0)		0 (0)
Organ failure	6 (13)	6 (35)		0 (0)		0 (0)
Early death, n (%)	1 (2)	1 (6)	.476	0 (0)	.804	0 (0)	.804
Total death, n (%)	24 (53)	11 (65)	.486	4 (36)	.142	9 (53)	.390
Causes of death, n (%)			.067		.062		< .999
Relapse	13 (27)	2 (12)		4 (36)		7 (41)
Infections	4 (9)	3 (18)		0 (0)		1 (6)
GVHD	2 (4)	2 (12)		0 (0)		0 (0)
Organ failure	5 (11)	4 (24)		0 (0)		1 (6)
OS, No. of Events (%)	24 (47)	11 (31)	.253	4 (47)	.046	9 (24)	.022
2-year OS	14 (69)	10 (39)	.018	1 (91)	.012	3 (80)	.492
4-year OS	20 (56)	11 (31)	.159	1 (91)	.005	8 (36)	.013
LFS, No. of Events (%)	27 (40)	11 (33)	.580	6 (41)	.111	10 (31)	.060
2-year LFS	21 (53)	11 (33)	.428	1 (91)	.005	9 (41)	.017
4-year LFS	24 (47)	11 (33)	.580	3 (72)	.021	10 (31)	.023
Hematologic relapse, No. of Events (%)	18 (40)	3 (20)	.148	6 (59)	.585	9 (67)	.083
2-year relapse	12 (27)	3 (20)	.226	1 (9)	.429	8 (56)	.025
4-year relapse	15 (33)	3 (20)	.148	3 (28)	.847	9 (67)	.034
NRM, No. of Events (%)	9 (20)	8 (47)	.008	0 (0)	.008	1 (6)	.421
1-year NRM	8 (18)	7 (41)	.019	0 (0)	.018	1 (6)	.421
2-year NRM	9 (20)	8 (47)	.008	0 (0)	.008	1 (6)	.421

Abbreviations: SCT, stem cell transplantation; MST, microtransplantation; Chemo, Chemotherapy; ANC, absolute neutrophil count; aGVHD, acute graft-versus-host disease; OS, overall survival; LFS, leukemia-free survival; NRM, non-relapse mortality.